NewEdge Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

NewEdge Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53,736	Closed	-$809K	–	4168
2025 Q4	$809K	Sell	53,736 -3,205	-6%	-$48.1K	﹤0.01%	1620
2025 Q3	$821K	Buy	56,941 +8,641	+18%	+$123K	﹤0.01%	1518
2025 Q2	$689K	Buy	48,300 +27,686	+134%	+$396K	﹤0.01%	1507
2025 Q1	$307K	Sell	20,614 -3,418	-14%	-$53.5K	﹤0.01%	1879
2024 Q4	$346K	Sell	24,032 -1,186	-5%	-$18.4K	﹤0.01%	1795
2024 Q3	$399K	Buy	25,218 +24,690	+4,676%	+$389K	﹤0.01%	1611
2024 Q2	$8.12K	Hold	528	–	–	﹤0.01%	2936
2024 Q1	$8.66K	Hold	528	–	–	﹤0.01%	2944
2023 Q4	$7.74K	Hold	528	–	–	﹤0.01%	2962
2023 Q3	$7.61K	Hold	528	–	–	﹤0.01%	2672
2023 Q2	$8.68K	Buy	528 +343	+185%	+$5.59K	﹤0.01%	2647
2023 Q1	$3.09K	Buy	185 +5	+3%	+$81	﹤0.01%	2920
2022 Q4	$3	Buy	+180	New	+$2.79K	﹤0.01%	3882

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

NewEdge Advisors's BMEZ Position: Q1 2026 in Review

NewEdge Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2026, closing a stake of 53,736 shares — an estimated $809K sold.

NewEdge Advisors first reported a position in BMEZ in Q4 2022 and held it in 13 quarters. The position peaked at $821K in Q3 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

NewEdge Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q1 2026 after selling out during the quarter.
NewEdge Advisors sold 53,736 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $809K.
NewEdge Advisors first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 13 quarters.
NewEdge Advisors's BlackRock Health Sciences Trust II position peaked at $821K in Q3 2025.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.